Literature DB >> 1673987

Polymorphism of the human Ig VH4 gene family.

K W van Dijk1, E H Sasso, E C Milner.   

Abstract

In this study, we analyze the human VH4 gene family and find it to exhibit a level of polymorphism similar to that of the much larger VH3 family. A cloned VH4 probe detected an average of 10 hybridizing BgIII restriction fragments in genomic DNA derived from 75 unrelated individuals and a total of 15 distinct bands. Of these 15 restriction fragments, 12 were polymorphic, as demonstrated by band absence in some individuals. Oligonucleotide probes specific to CDR1 and CDR2 sequences of known VH4 genes detected limited numbers of bands and revealed sequence polymorphisms that correlated with several of the RFLP detected by the cloned probe. The prevalence of the individual polymorphic restriction fragments was highly variable, ranging from 1% to 97%, with a mean prevalence of 51%. These values resemble those previously observed among VH3 elements. Analysis of linkage disequilibrium suggests that most VH4 gene segments are in genetic equilibrium. These results indicate that the VH4 loci, like those of VH3, are dominated by relatively few, perhaps two to four, alleles/locus and further suggest that the haplotype organization of the human VH locus is very complex.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1673987

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Direct detection of insertion/deletion polymorphisms in an autosomal region by analyzing high-density markers in individual spermatozoa.

Authors:  Sreemanta Pramanik; Honghua Li
Journal:  Am J Hum Genet       Date:  2002-11-19       Impact factor: 11.025

2.  Analysis of human VH gene repertoire expression in peripheral CD19+ B cells.

Authors:  C Demaison; D David; F Letourneur; J Thèze; S Saragosti; M Zouali
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

3.  Determination of gene organization in individual haplotypes by analyzing single DNA fragments from single spermatozoa.

Authors:  X Cui; H Li
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

4.  Lack of intraclonal diversification in Ig heavy and light chain V region genes expressed by CD5+IgM+ chronic lymphocytic leukemia B cells: a multiple time point analysis.

Authors:  E W Schettino; A Cerutti; N Chiorazzi; P Casali
Journal:  J Immunol       Date:  1998-01-15       Impact factor: 5.422

5.  Ethnic differences of polymorphism of an immunoglobulin VH3 gene.

Authors:  E H Sasso; J H Buckner; L A Suzuki
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

6.  A fetally expressed immunoglobulin VH1 gene belongs to a complex set of alleles.

Authors:  E H Sasso; K Willems van Dijk; A P Bull; E C Milner
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

7.  Human B cells accumulate immunoglobulin V gene somatic mutations in a cell contact-dependent manner in cultures supported by activated T cells but not in cultures supported by CD40 ligand.

Authors:  S C Huang; A M Glas; G V Pinchuk; E H Van Montfort; S P Rao; R Jiang; E C Milner
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

Review 8.  Human innate B cells: a link between host defense and autoimmunity?

Authors:  Eric C B Milner; Jennifer Anolik; Amedeo Cappione; Iñaki Sanz
Journal:  Springer Semin Immunopathol       Date:  2005-01-05

9.  Sequence analysis of immunoglobulin heavy-chain variable region genes from the synovium of a rheumatoid arthritis patient shows little evidence of mutation but diverse CDR3.

Authors:  C M Brown; K J Fitzgerald; S P Moyes; R A Mageed; D G Williams; R N Maini
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

10.  Chromosomal organization of the heavy chain variable region gene segments comprising the human fetal antibody repertoire.

Authors:  K Willems van Dijk; L A Milner; E H Sasso; E C Milner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.